Ep. 475 Bariatric Embolization for Obesity Management with Dr Cliff Weiss episode artwork

EPISODE · Aug 20, 2024 · 46 MIN

Ep. 475 Bariatric Embolization for Obesity Management with Dr Cliff Weiss

from BackTable Vascular & Interventional · host BackTable

While GLP-1 agonists continue to gain popularity in the medical management of diabetes and obesity, Dr. Cliff Weiss is exploring bariatric arterial embolization (BAE) as an adjunctive therapy to help patients sustain weight loss. Dr. Weiss, the Director of IR Research at Johns Hopkins, joins the show to discuss the techniques and impacts of BAE for obesity treatment. --- CHECK OUT OUR SPONSOR Reflow Medical https://www.reflowmedical.com/ --- SYNPOSIS Dr. Weiss outlines his initial research interest in gastric embolization of the fundus to reduce ghrelin production. He began by studying the use of sclerosants for embolization but later shifted to using embolic spheres. BAE involves the targeted embolization of the left gastric artery, with or without the left gastroepiploic artery, using 300-500 micron embolic spheres. Dr. Weiss also employs a dilute mixture of spheres and a vasodilator to achieve distal arterial penetration. He describes the role of BAE in conjunction with existing surgical and pharmaceutical treatments. According to his experience, patients undergoing BAE achieve maximum weight loss 6-9 months after the procedure and can maintain this weight when they follow up in a weight management clinic. Additionally, Dr. Weiss reviews data from BAE studies, including the BEAT Obesity Trial and the recent BEATLES Trial. --- TIMESTAMPS 00:00 - Introduction 03:21 - Early Research and Development of BAE 07:39 - Potential Role of BAE in Obesity Treatment 16:03 - Procedure Details 25:28 - Post-Procedure Care and Patient Management 28:06 - Insights from the BEAT Obesity Trial 33:38 - BEATLES Trial 37:38 - Combination Therapy for Obesity --- RESOURCES BEAT Obesity Trial: https://pubs.rsna.org/doi/full/10.1148/radiol.2019182354 LC Bead/Bead Block: https://www.bostonscientific.com/en-US/products/embolization/lc-bead.html EmboSpheres: https://www.merit.com/product/embosphere-microspheres/ EMBIO Trial: https://bmjopen.bmj.com/content/13/9/e072327 BEATLES Trial: https://www.jvir.org/article/S1051-0443(23)01155-7/fulltext

While GLP-1 agonists continue to gain popularity in the medical management of diabetes and obesity, Dr. Cliff Weiss is exploring bariatric arterial embolization (BAE) as an adjunctive therapy to help patients sustain weight loss. Dr. Weiss, the Director of IR Research at Johns Hopkins, joins the show to discuss the techniques and impacts of BAE for obesity treatment. --- CHECK OUT OUR SPONSOR Reflow Medical https://www.reflowmedical.com/ --- SYNPOSIS Dr. Weiss outlines his initial research interest in gastric embolization of the fundus to reduce ghrelin production. He began by studying the use of sclerosants for embolization but later shifted to using embolic spheres. BAE involves the targeted embolization of the left gastric artery, with or without the left gastroepiploic artery, using 300-500 micron embolic spheres. Dr. Weiss also employs a dilute mixture of spheres and a vasodilator to achieve distal arterial penetration. He describes the role of BAE in conjunction with existing surgical and pharmaceutical treatments. According to his experience, patients undergoing BAE achieve maximum weight loss 6-9 months after the procedure and can maintain this weight when they follow up in a weight management clinic. Additionally, Dr. Weiss reviews data from BAE studies, including the BEAT Obesity Trial and the recent BEATLES Trial. --- TIMESTAMPS 00:00 - Introduction 03:21 - Early Research and Development of BAE 07:39 - Potential Role of BAE in Obesity Treatment 16:03 - Procedure Details 25:28 - Post-Procedure Care and Patient Management 28:06 - Insights from the BEAT Obesity Trial 33:38 - BEATLES Trial 37:38 - Combination Therapy for Obesity --- RESOURCES BEAT Obesity Trial: https://pubs.rsna.org/doi/full/10.1148/radiol.2019182354 LC Bead/Bead Block: https://www.bostonscientific.com/en-US/products/embolization/lc-bead.html EmboSpheres: https://www.merit.com/product/embosphere-microspheres/ EMBIO Trial: https://bmjopen.bmj.com/content/13/9/e072327 BEATLES Trial: https://www.jvir.org/article/S1051-0443(23)01155-7/fulltext

NOW PLAYING

Ep. 475 Bariatric Embolization for Obesity Management with Dr Cliff Weiss

0:00 46:40

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

First Incision Amanda Nikolic A podcast about preparing for the General Surgery Fellowship Exam. Each year, Australian and New Zealand surgical trainees sit this exam in order to gain a 'fellowship' in General Surgery. This podcast follows one trainee doctor on her journey towards FRACS (Fellowship Royal Australian College of Surgeons). The series correspond to the different modules from the surgical curriculum. Series 1-Breast Surgery, 2-Exam Specific Episodes; 3-Upper Gastrointestinal Surgery; 4-Colorectal Surgery; 5-Hepatobiliary Surgery; 6-Endocrine Surgery; 7-Trauma; 8-Skin and Soft Tissue; 9-Vascular; 10-Anatomy (Limb); 11-Surgical Oncology; 12-Critically Ill Surgical Patient Pain Unfiltered American Society of Pain & Neuroscience Welcome to Pain Unfiltered, where we go in depth into the interventional pain and spine world with some of the top key opinion leaders and executives in the space. We are your hosts, Dr. Patrick Buchanan and Dr. Timothy Deer for this ASPN podcast. The Interventional Endoscopist Mankanwal Sachdev A podcast about technology, devices, and techniques in the therapeutic endoscopy space Life of Flow Lucas Ferrer and Miguel Montero-Baker Life of Flow is a podcast hosted by two experts in the field of vascular surgery, Miguel-Montero Baker and Lucas Ferrer Cardona. They share their thoughts, insights, and expertise with their listeners each week, discussing a wide range of topics that are both related to and beyond vascular surgery.In addition to talking about the latest research and developments in the field, the hosts also share anecdotes and personal stories that provide a unique perspective on the world of vascular surgery. They delve into the challenges that they have faced, the lessons that they have learned, and the unique life of a vascular surgeon.

Frequently Asked Questions

How long is this episode of BackTable Vascular & Interventional?

This episode is 46 minutes long.

When was this BackTable Vascular & Interventional episode published?

This episode was published on August 20, 2024.

What is this episode about?

While GLP-1 agonists continue to gain popularity in the medical management of diabetes and obesity, Dr. Cliff Weiss is exploring bariatric arterial embolization (BAE) as an adjunctive therapy to help patients sustain weight loss. Dr. Weiss, the...

Can I download this BackTable Vascular & Interventional episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!